Shareholders that Lost Money on Neumora Therapeutics, Inc. (NMRA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Portfolio Pulse from
Law firm Levi & Korsinsky is pursuing a class action lawsuit against Neumora Therapeutics (NMRA) alleging the company made false statements and concealed critical information about its Phase Two clinical trials for Navacaprant, a therapeutic candidate for Major Depressive Disorder (MDD). The lawsuit claims Neumora manipulated trial inclusion criteria and statistical analysis to show potential efficacy.
March 21, 2025 | 5:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Class action lawsuit alleges manipulation of clinical trial data, which could negatively impact investor confidence and stock performance.
The lawsuit directly targets Neumora Therapeutics, alleging serious misrepresentations in clinical trial data. Such legal challenges typically create investor uncertainty, potentially leading to stock price decline.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100